Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L9 pseudogene 25 (RPL9P25) is a processed pseudogene in the human genome, arising as a non-functional copy of the functional ribosomal protein L9 gene (RPL9)[8][2][5]. Pseudogenes like RPL9P25 are widespread, especially for ribosomal proteins, due to retrotransposition events and gene duplication in mammalian genomes[5]. RPL9P25 does not produce a functional protein and is not involved in any known biological process or disease mechanism. It is listed only in genomic databases with no evidence of it serving as a therapeutic target, biomarker, or playing a disease role[8][2][5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L9 pseudogene 25 (RPL9P25).